Tuesday, August 01, 2023 1:55:50 PM
mate,
I spent some time organizing all the selling records of NVCR management. Seems like you are still not convinced. Otherwise you would realize JC is one of the gangsters feeding you the wrong information.
Take a look how many times t-cells were increased 4 and 8 months after three doses of DCVax-L within 28 days. You are good at simple math, right? Keep in mind
NVCR will struggle on the brink of bankruptcy once DCVax-L gets approval. This may hurt your feeling. But the principle of “fearful when others are greedy, and greedy when others are fearful.” does not apply to you since you lack of fundamental understanding of both NWBO and NVCR.
I spent some time organizing all the selling records of NVCR management. Seems like you are still not convinced. Otherwise you would realize JC is one of the gangsters feeding you the wrong information.
Take a look how many times t-cells were increased 4 and 8 months after three doses of DCVax-L within 28 days. You are good at simple math, right? Keep in mind
Background in normal, unstimulated individuals would be 2 – 20 clones
NVCR will struggle on the brink of bankruptcy once DCVax-L gets approval. This may hurt your feeling. But the principle of “fearful when others are greedy, and greedy when others are fearful.” does not apply to you since you lack of fundamental understanding of both NWBO and NVCR.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
